For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Expermental Fluoride Application | The two-step system, consisting of Component A (ammonium fluoride solution) and Component B (calcium fluoride application), will be applied once on the white spot lesions one. Fluoride Application (Experimental Fluoride Application): Fluoride containing applications are applied on white spot lesions. First solution was air-dried before the second application with the other component was done. | 0 | None | 1 | 23 | 0 | 23 | View |
| Fluor Protector S | The ammonium fluoride gel will be applied once on the white spot lesions. Fluor Protector S: Fluor Protector S is applied on white spot lesions. | 0 | None | 1 | 23 | 0 | 23 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| osteosarcoma | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |